QXL-138AM | m-entrepreneurship.com

Product Name :
QXL-138AM

Search keywords :
CD138

drugId :
null

Target Vo:
Syndecan-1

Target Vo Short Name :
SDC1

Moa_Name:
Anti-CD138

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nammi Therapeutics Inc

Active Company_Name :
Nammi Therapeutics Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Myc-tag Mouse mAb Autophagy
Caspase-5 p20 Antibody Technical Information
FIP200 Antibody: FIP200 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to FIP200. It can be used for WB assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts